Compare BLLN & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | KNX |
|---|---|---|
| Founded | 2016 | 1989 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 7.0B |
| IPO Year | N/A | 2010 |
| Metric | BLLN | KNX |
|---|---|---|
| Price | $132.63 | $76.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 20 |
| Target Price | ★ $126.71 | $65.00 |
| AVG Volume (30 Days) | 706.5K | ★ 3.5M |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,469,689,000.00 |
| Revenue This Year | $46.29 | $6.91 |
| Revenue Next Year | $30.14 | $7.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.80 |
| 52 Week Low | $61.96 | $38.63 |
| 52 Week High | $138.70 | $82.86 |
| Indicator | BLLN | KNX |
|---|---|---|
| Relative Strength Index (RSI) | 64.49 | 53.27 |
| Support Level | $79.07 | $72.69 |
| Resistance Level | $138.70 | $78.88 |
| Average True Range (ATR) | 7.07 | 2.41 |
| MACD | -0.17 | -0.09 |
| Stochastic Oscillator | 92.55 | 64.79 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the US Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.